Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2025-12-24 @ 9:42 PM
NCT ID:
NCT02079532
Eligibility Criteria:
Inclusion Criteria:
* adult patients, 18-75 years of age;
* rheumatoid arthritis for \>=6 months;
* previous inadequate response to a single anti-TNF alpha inhibitor;
* methotrexate at a stable dose range 7.5-25 mg/week.
Exclusion Criteria:
* other chronic inflammatory articular disease or systemic autoimmune disease;
* previous treatment with MabThera or intolerance to MabThera;
* corticosteroids\>=10 mg/day prednisolone within last 2 weeks, or corticosteroids at unstable doses within last 2 weeks;
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02079532
Study Brief:
Protocol Section:
NCT02079532